Default company panoramic image

Spirosure Inc

Spirosure will revolutionize the management of asthma by bringing to market a low cost point of care nitric oxide measurement device.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Fremont, CA, USA
  • Currency USD
  • Founded November 2011
  • Employees 2
  • Website

Company Summary

Much as home glucose monitoring has revolutionized the management of diabetes, home asthma monitoring will revolutionize the management of asthma with the benefit of fewer emergency room visits, better medical control of disease, and reduced overall healthcare costs. The migration to point of care sensors is enabled by a solid state chemical sensor that permits miniaturization of the detection of nitric oxide, a marker of airway inflammation.


  • Default avatar
    Solomon Ssenyange

    Founder Solomon Ssenyange, who serves as both Chief Executive and Chief Technology Officer, has worked as a senior scientist in sensor development and analytical chemistry for over 8 years. Dr. Ssenyange has been associated with The Ohio State University where he licensed the current Spirosure technology and IP with the desire to improve asthma management and diagnostic accuracy at the point of care.

  • Default avatar
    Vivek Balasubramanyam
    VP of Product Engineering

    Vice-President of Product Engineering Vivek Balasubramanyam, former Systems Engineer at Aperion Inc. has product development experience and is an experienced materials scientist with over 10 years’ experience in the area of process development in the area of semiconductors. Vivek has been instrumental in getting 510(k) approval of an NO asthma device.


  • Default avatar
    Casey McGlynn, Elton Satusky
    Default avatar

Previous Investors

  • Default avatar